Login / Signup

Pro Re Nata brolucizumab for early onset and treatment-naïve diabetic macular edema: A prospective study.

Alper BilgicLaurent KodjikianAditya SudhalkarJesus Hernan Gonzalez-CortesFrancesc March de RibotRiddhima DeshpandeMartin S SpitzerThibaud Mathis
Published in: European journal of ophthalmology (2024)
Brolucizumab therapy for DME is a safe and effective modality for the treatment of recent DME and has the potential to reduce the number of injections.
Keyphrases
  • early onset
  • late onset
  • combination therapy
  • climate change
  • anti inflammatory
  • ultrasound guided
  • human health